Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study

Ann Intern Med. 2021 Oct;174(10):1483-1487. doi: 10.7326/M21-1375. Epub 2021 Jul 20.

Authors

Ashley Kieran Clift¹, Defne Saatci¹, Carol A C Coupland², Hajira Dambha-Miller³, Julia Hippisley-Cox¹; International Investigator Group for Ethnicity and COVID-19

Collaborators

International Investigator Group for Ethnicity and COVID-19:
Pui San Tan, Martina Patone, Francesco Zaccardi, Baiju R Shah, Simon J Griffin, Kamlesh K Khunti

Affiliations

¹ University of Oxford, Oxford, United Kingdom.
² University of Nottingham, Nottingham, United Kingdom.
³ University of Southampton, Southampton, United Kingdom.

No abstract available

MeSH terms

Adolescent
Adult
Aged
Anemia, Sickle Cell / complications*
COVID-19 / complications*
COVID-19 / mortality
Child
Child, Preschool
Female
Hospitalization*
Humans
Infant
Infant, Newborn
Male
Middle Aged
SARS-CoV-2
Young Adult

Grants and funding